Phase III clinical trial of favipiravir in early-onset COVID-19 patients with severe risk factors : Phase III clinical trial of favipiravir in early-onset COVID-19 patients with severe risk factors-Placebo-controlled, stratified Randomized, Multicenter, Double-blind study -

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 10. Okt. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19 patients with risk factors of progression to severe disease onset within 72 hours prior to
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 14-04-2021, Last updated: 2022-11-24

ICTRP ID:

JPRN-jRCT2041210004

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007597835